Revolutionary nano-medicine offers new hope for children and families
The Next Chapter in Autism Care
When your child lives with autism, you never stop searching for answers. You explore every therapy, research every breakthrough, and hope for treatments that could help your child thrive. Today, cutting-edge science is opening an extraordinary new pathway through the smallest messengers in medicine: exosomes.
These remarkable nano-sized cellular packages are transforming how we understand and treat autism, offering families genuine hope for meaningful improvements in communication, social connection, and quality of life.
Understanding the Brain-Body Connection in Autism
At least 69% of individuals with an autism diagnosis have microglial activation or neuroinflammation, revealing that autism involves complex biological processes throughout the body. Children with autism often experience:
Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β, showing how the body's own cellular messengers become disrupted in autism.
The Revolutionary Discovery: Nature's Cellular Messengers
Exosomes are tiny cellular packages, measuring just 30-150 nanometers, that naturally transport healing messages between cells throughout the body. Exosomes extracted from human umbilical cord MSCs are able to alleviate brain neuroinflammation by regulating the activation of microglia, offering a targeted approach to address autism's underlying causes.
What Makes Exosomes Extraordinary:
Precision Delivery System Exosomes have a small size (30–150 nm) and are constituted by a lipid bilayer, characteristics that permit their easy crossing of the BBB. Unlike medications that affect the entire body, exosomes can cross the blood-brain barrier and deliver therapeutic cargo directly to brain cells that need healing.
Advanced Therapeutic Cargo Each exosome carries over 200 different healing molecules, including:
Natural Healing Intelligence Exosomes are able to migrate and home in on different targeted brain areas, driven by neuroinflammatory signals. These cellular messengers naturally seek out areas of the brain that need healing, concentrating their therapeutic effects where they're needed most.
How Exosomes Transform Brain Function in Autism
Mechanism of Action: Cellular Repair and Restoration
Reducing Harmful Brain Inflammation Recent findings indicate that neuroinflammation is involved in ASD pathogenesis, as a result of increased pro-inflammatory cytokine levels and microglia/astrocyte aberrant responses in the autistic brain. Exosomes work by:
Repairing Cellular Communication Autism often involves disrupted communication between brain cells. Through the transfer of their molecules via endocytosis or ligand-receptor interactions, exosomes communicate directly or indirectly with endogenous brain cells. Exosomes help by:
Promoting Neural Development MSCs-derived exosomes can improve functional recovery, rescue pattern separation and spatial learning impairments, promote neurovascular remodeling (neurogenesis). This process includes:
Remarkable Clinical Evidence
Groundbreaking Animal Studies Show Dramatic Improvements
Duke University Research Success Intranasal administration of MSC-exo increased male to male social interaction and reduced repetitive behaviors. In this landmark study:
International Research Validation Treated BTBR mice showed increased social interaction and decreased repetitive behaviors after three weeks post-exosome treatment; ultrasonic vocalization and maternal pup retrieval were also improved. Multiple research centers have confirmed:
Advanced Molecular Research Administration of serum exosomes from rats with valproic acid-induced ASD resulted in ASD-related phenotypes in mice, whereas exosomes from normal rats did not exhibit such effects. This research reveals:
Multiple Delivery Methods for Optimal Results
Intranasal Administration: Direct Brain Access Exosomes from human umbilical cord mesenchymal stem cells (hUC-MSCs) that efficiently enter the brain tissue through the intranasal route restore the social ability of the mice and correct the repeated stereotyped behaviors. Benefits include:
Intravenous Delivery: Systemic Approach Therapeutic exosomes could be intravenously administered in ASD subjects, so the nanoparticles move toward the higher brain center through the permeable BBB and exert their effects in ameliorating brain neuroinflammation in situ. This method offers:
Safety Profile: Gentle Yet Powerful
Outstanding Safety Record No negative symptoms were detected following MSC-exo intranasal treatments in BTBR or healthy C57BL mice. Clinical evidence shows:
Natural Biocompatibility
Advanced Safety Features Compared to stem cells, stem cell-derived exosomes possess numerous advantages, such as non-immunogenicity, non-infusion toxicity, easy access, effortless preservation, and freedom from tumorigenic potential. Key safety advantages include:
What Families Can Expect
Timeline for Improvements The behavioral effect seemed 3 weeks post the treatment. The behavioral amelioration was seen in all the core symptoms including social interaction, repetitive behaviors, and vocal communication. Families typically observe:
Weeks 1-3: Initial Changes
Weeks 4-8: Expanding Progress
Months 2-6: Continued Development
The Future of Autism Treatment
Global Clinical Development Exosome-based diagnostics and therapeutics are expanding, with 388 clinical trials currently underway. The field is rapidly advancing with:
Precision Medicine Approach Exosomes are progressively known as significant mediators of cell-to-cell communication. They convey active biomolecules to target cells and show substantial promise as novel treatment strategies for diseases. Future developments include:
Taking the Next Step
Exosome therapy represents a revolutionary advancement in autism care, offering hope where traditional treatments have fallen short. Treatment of mesenchymal stem cells derived exosomes leads to significant behavioral improvement of both genetic and idiopathic autism, demonstrating effectiveness across different autism types.
This breakthrough treatment works with your child's natural healing systems to address autism's underlying causes while supporting healthy brain development. Children around the world are experiencing meaningful improvements in communication, social connection, and overall quality of life.
Ready to explore this groundbreaking treatment for your child?
Our medical team specializes in exosome therapy for autism and can help determine if this revolutionary treatment is right for your family. We'll work with you to develop a personalized treatment plan designed to maximize your child's potential.
Schedule your consultation today to learn how exosome therapy could transform your child's journey with autism.
References:
¹ Tsilioni, I. & Theoharides, T. C. Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β. J. Neuroinflammation 15, 239 (2018).
² Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D. Stem Cell-Derived Exosomes in Autism Spectrum Disorder. Int J Environ Res Public Health. 2020;17(3):944.
³ Perets N, Hertz S, London M, Offen D. Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice. Mol Autism. 2018;9:57.
⁴ Chen L, Xiong XY, Yao TT, Gui LN, Luo F, Du Y, Cheng Y. Blood exosome sensing via neuronal insulin-like growth factor-1 regulates autism-related phenotypes. Pharmacol Res. 2023;197:106965.
⁵ Suzuki A, Stern SA, Bozdagi O, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144(5):810-823.
⁶ Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke. Proc Natl Acad Sci U S A. 2013;110(39):15686-15691.
⁷ Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852.
⁸ Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9:63.
⁹ Gimona M, Pachler K, Laner-Plamberger S, Schallmoser K, Rohde E. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18(6):1190.
¹⁰ Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6:127.
¹¹ Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017;7:278-287.
¹² Wu P, Zhang B, Shi H, Qian H, Xu W. MSC-exosome: a novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018;20(3):291-301.
¹³ Mendt M, Kamerkar S, Sugimoto H, et al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018;3(8):e99263.
¹⁴ Liew LC, Katsuda T, Gailhouste L, Nakagama H, Ochiya T. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease. Int Immunol. 2017;29(1):11-19.
¹⁵ Börger V, Bremer M, Ferrer-Tur R, et al. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci. 2017;18(7):1450.
¹⁶ Yu B, Shao H, Su C, et al. Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci Rep. 2016;6:34562.
¹⁷ Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.
Stem Cell Therapy
Adapting the regenerative properties of cord blood-derived stem cells, this treatment offers a promising approach for managing Crohn's Disease. It focuses on promoting intestinal healing and reducing inflammation at a cellular level. These stem cells are instrumental in repairing damaged intestinal tissues, potentially alleviating symptoms and improving gut health. Additionally, the treatment modulates the immune response, addressing the underlying autoimmune aspects of Crohn's Disease. With consistent application, it promises long-term improvements in gastrointestinal health and overall well-being, complementing holistic treatment strategies for Crohn's Disease.
At Regenecell, our dedication to potentially enhancing quality of life alleviating pain and rebuilding tissue is rooted in the exceptional quality of our cord blood-derived stem cells. Sourced from the umbilical cord tissue of healthy U.S. mothers, we capitalize on the rejuvenating potential of cord blood-derived stem cells. Through our unique, scientifically refined protocols, these cells undergo meticulous cultivation and expansion in a state-of-the-art laboratory, which is FDA-registered and AABB-accredited.
We place immense importance on stringent testing, guaranteeing that our stem cells surpass the highest standards of purity and efficacy. This commitment to excellence ensures that the stem cells we utilize are ideally suited for alleviating pain and rebuilding tissue potentially enhancing quality of life.
Our premium stem cell treatments stand out for their exceptional efficacy, safety, and advanced technology, offering significant therapeutic benefits tailored to individual needs.
Sourced from healthy U.S. donors, our cord blood-derived stem cells guarantee superior quality and reliability, forming a crucial foundation for effective therapeutic applications.
Stem cells versatilely applicable across a wide spectrum of conditions, offering broad therapeutic potential and adaptability.
Cord-blood derived cells, meticulously produced in state-of-the-art laboratories, represent a pinnacle of medical innovation, offering potent therapeutic potential.
Stem cells boost quality of life by repairing tissues and rejuvenating health, benefiting a variety of medical conditions.